Immunicon Corporation

Company Information
Address Immunicon Corporation
3401 Masons Mill Rd, Ste 100
Huntingdon Valley, PA, 19006


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Gene Expression in Circulating Tumor Cells

    Amount: $1,089,994.00

    DESCRIPTION (provided by applicant): The informed development of new treatments for cancer would be greatly facilitated if tumor cells could be directly sampled at multiple time points following the a ...

    STTRPhase II2005Department of Health and Human Services
  2. Gene Expression in Circulating Tumor Cells

    Amount: $100,000.00

    N/A

    STTRPhase I2003Department of Health and Human Services
  3. Analysis of Circulating Cancer Cells Early in Disease

    Amount: $0.00

    DESCRIPTION: (provided by applicant) The long term objective of this proposal is commercialization of a test for the management of cancer. Imm ...

    SBIRPhase I2001Department of Health and Human Services
  4. Analysis of Circulating Cancer Cells Early in Disease

    Amount: $309,500.00

    DESCRIPTION: (provided by applicant) The long term objective of this proposal is commercialization of a test for the management of cancer. Imm ...

    SBIRPhase II2001Department of Health and Human Services
  5. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  6. BIOPROCESSING USING BIORECEPTOR FERROFLUIDS AND HGMS

    Amount: $383,836.00

    THE LONG-TERM OBJECTIVE IS TO DEVELOP A NEW TECHNOLOGY FOR INDUSTRY SCALE AFFINITY SEPARATIONS EMPLOYING PROPRIETARY BIO- RECEPTOR FERROFLUIDS (BR-FF) IN COMBINATION WITH EXISTING HIGH GRADIENT MAGNET ...

    SBIRPhase II1992Department of Health and Human Services
  7. BIOPROCESSING CELLS FROM BLOOD USING BR-FF AND HGMS

    Amount: $50,000.00

    THE LONG TERM OBJECTIVE IS TO DEVELOP A NEW TECHNOLOGY FOR INDUSTRY SCALE AFFINITY SEPARATIONS EMPLOYING PROPRIETARY BIO-RECEPTOR FERROFLUIDS (BR-FF) IN COMBINATION WITH EXISTING CONTINUOUS HIGH GRADI ...

    SBIRPhase I1991Department of Health and Human Services
  8. BIOPROCESSING USING BIORECEPTOR FERROFLUIDS AND HGMS

    Amount: $50,000.00

    N/A

    SBIRPhase I1991Department of Health and Human Services
  9. FEASIBILITY STUDIES FOR DEVELOPING A NOVEL CLINICAL DEVICE ARE PROPOSED.

    Amount: $50,000.00

    FEASIBILITY STUDIES FOR DEVELOPING A NOVEL CLINICAL DEVICE ARE PROPOSED. THIS DEVICE WHICH WOULD USE IMMUNOLOGICAL AND COMPLEMENT REAGENTS IN CONJUNCTION WITH FILTRATION AND/OR ONE OR MORE MAGNETIC RE ...

    SBIRPhase I1985Department of Health and Human Services
  10. Gene Expression in Circulating Tumor Cells

    Amount: $1,089,990.00

    DESCRIPTION (provided by applicant): The informed development of new treatments for cancer would be greatly facilitated if tumor cells could be directly sampled at multiple time points following the a ...

    SBIRPhase IIDepartment of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government